Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,052
Closed -$666K 1100
2024
Q2
$666K Sell
13,052
-86,599
-87% -$4.42M ﹤0.01% 921
2024
Q1
$5.48M Sell
99,651
-28,402
-22% -$1.48M 0.02% 537
2023
Q4
$7.15M Buy
+128,053
New +$5.79M 0.02% 471
2023
Q1
Sell
-286,600
Closed -$19.2M 1118
2022
Q4
$19.2M Buy
286,600
+85,200
+42% +$5.9M 0.07% 312
2022
Q3
$14.3M Sell
201,400
-40,000
-17% -$3.15M 0.06% 353
2022
Q2
$17.7M Buy
241,400
+205,500
+572% +$16.6M 0.07% 319
2022
Q1
$3.25M Buy
35,900
+9,900
+38% +$934K 0.01% 752
2021
Q4
$2.26M Sell
26,000
-166,300
-86% -$14.3M 0.01% 820
2021
Q3
$15.5M Hold
192,300
0.04% 387
2021
Q2
$13.7M Buy
+192,300
New +$14.3M 0.04% 446
2020
Q4
Sell
-158,983
Closed -$6.08M 1274
2020
Q3
$6.08M Buy
+158,983
New +$6.11M 0.02% 571
2019
Q3
Sell
-281,649
Closed -$20.5M 1311
2019
Q2
$20.5M Buy
281,649
+208,800
+287% +$15.5M 0.08% 296
2019
Q1
$5.34M Buy
72,849
+14,211
+24% +$1.14M 0.02% 632
2018
Q4
$4.03M Buy
58,638
+26,200
+81% +$2.08M 0.02% 663
2018
Q3
$2.93M Buy
32,438
+15,900
+96% +$1.52M 0.01% 805
2018
Q2
$1.5M Sell
16,538
-111
-0.7% -$10.6K 0.01% 919
2018
Q1
$1.6M Sell
16,649
-75,700
-82% -$7.22M 0.01% 899
2017
Q4
$8.02M Buy
92,349
+71,749
+348% +$5.77M 0.03% 537
2017
Q3
$1.57M Hold
20,600
0.01% 859
2017
Q2
$1.51M Buy
20,600
+200
+1% +$14K 0.01% 839
2017
Q1
$1.4M Buy
+20,400
New +$1.42M 0.01% 856
2016
Q2
Sell
-15,900
Closed -$602K 1371
2016
Q1
$602K Buy
+15,900
New +$573K ﹤0.01% 964
2015
Q1
Sell
-31,900
Closed -$1.49M 1435
2014
Q4
$1.49M Buy
31,900
+2,700
+9% +$127K 0.01% 869
2014
Q3
$1.46M Buy
29,200
+2,100
+8% +$105K 0.01% 830
2014
Q2
$1.36M Sell
27,100
-3,600
-12% -$176K 0.01% 860
2014
Q1
$1.59M Sell
30,700
-1,211,000
-98% -$58.3M 0.01% 823
2013
Q4
$59M Buy
1,241,700
+25,850
+2% +$1.14M 0.26% 100
2013
Q3
$47.8M Buy
1,215,850
+32,683
+3% +$1.36M 0.24% 113
2013
Q2
$47.1M Buy
+1,183,167
New +$44.2M 0.25% 100

Other funds holding CMA

Axa's CMA Position: Q3 2024 in Review

Axa sold out of Comerica (CMA) in Q3 2024, closing a stake of 13,052 shares — an estimated $666K sold.

Axa first reported a position in CMA in Q2 2013 and held it in 29 quarters. The position peaked at $59M in Q4 2013. 530 funds tracked by Wall St. Rank hold CMA as of Q3 2024.

  • Axa reported no remaining Comerica position as of Q3 2024 after selling out during the quarter.
  • Axa sold 13,052 Comerica shares in Q3 2024, an estimated $666K.
  • Axa first reported a position in Comerica in Q2 2013 and held it in 29 quarters.
  • Axa's Comerica position peaked at $59M in Q4 2013.
  • 530 funds tracked by Wall St. Rank held Comerica as of Q3 2024.

Based on Axa's 13F filing for Q3 2024, filed 14 Nov 2024.